Publications

  1. McEachron J, Heyman T, Shanahan L, Tran V, Friedman M, Economos K, Gorelick C, Singhal P, Lee YC, Kanis MJ.  Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma. (2020) Int J Gynecol Cancer. In press April 2020.

  2. McEachron J, Sabir S, Bennett M, Lee YC, Kanis MJ.  Noninvasive negative pressure wound therapy decreases postoperative complications in patients undergoing laparotomy for benign gynecologic indications and gynecologic malignancy. (2020) Int J Gynecol Clin Pract. 2020; 7: 153. Doi.org/15344/2394-4986/2020/153.

  3. McEachron J, Hastings V, Malakhov N, Gorelick C, Economos K, Lee YC, Kanis MJ.  Clinically significant discrepancy between clinical and pathologic stage of early operable cervical cancer. (2020) Clin Oncol Research. 2020. 3(4): 1-5. Doi:10.31487/j.COR.2020.04.06

  4. McEachron J, Chatterton C, Hastings V, Gorelick C, Economos K, Lee YC, Kanis MJ.  A clinicopathologic study of endometrial cancer metastatic to bone: Identification of microsatellite instability improves treatment strategies. (2020) Gynecol Oncol Rep. 2020 Feb 10; 32:100549. PMID: 32099892

  5. McEachron J, Mendoza R, Lee YC, Kanis MJ.  Breast metastases: A rare manifestation of advanced uterine serous carcinoma. (2019) Gynecol Oncol Rep. 2019 Oct 5; 30: 100500. PMID: 31656850

  6. Gibbs J, Mei S, Economos K, Lee YC, Kanis MJ.  Clinicopathologic features, incidence and survival trends of gynecologic neuroendocrine tumors; a SEER data base analysis. (2019) Am J Obstet Gynecol. 2019 Mar 5 (19):30431-4. [Epub ahead of print]. PMID: 30849352

  7. Salman B, Momeni-Boroujeni A, Kanis M, Lee YC.  Cervical rhabdomyosarcoma in an endocervical polyp of a 50 year old patient with intermenstrual bleeding. (2019) Gynecol Oncol Rep. 2019 Jan 26; 28:6-8. PMID: 30740507

  8. Sheu J, Palileo A, Chen MY, Hoepner L, Abulafia O, Kanis MJ, Lee YC.  Hospice utilization in advanced cervical malignancies: An analysis of the National Inpatient Sample. (2019) Gynecol Oncol. 2019 Mar; 152(3):594-598. PMID: 30587442

  9. Mei S, Gibbs J, Economos K, Lee Y, Kanis MJ.  Clinical comparison between neuroendocrine and endometrioid type carcinoma of the uterine corpus. (2019) J Gynecol Oncol. 2019 Jul; 30(4):e58; in press.

  10. Wong AT, Lee YC, Schwartz D, Lee A, Shao M, Han P, Choi K, Schreiber D.  Use of Adjuvant Chemotherapy, Radiation Therapy, or Combined Modality Therapy and the Impact on Survival for Uterine Carcinosarcoma Limited to the Pelvis. (2017) Int J Gynecol Cancer. 27(6):1171-1177. 2017 Jun. PMID: 28574930.

  11. Safdieh J, Lee YC, Wong A, Lee A, Weiner J, Schwartz D, Schreiber D.  A Comparison of Outcomes between Open Hysterectomy and Robotic-Assisted Hysterectomy for Endometrial Cancer Using the National Cancer Database. (2017) Int J Gynecol Cancer. 27(7): 1508–1516. September 2017.

  12. Alagkiozidis I, Gorelick C, Shah T, Chen YA, Gupta V, Stefanov D, Amarnani A, Lee YC, Abulafia O, Sarafraz-Yazdi E, Michl J. Synergy between Paclitaxel and Anti-Cancer Peptide PNC-27 in the Treatment of Ovarian Cancer. (2017) Ann Clin Lab Sci.47(3):271-281. PMID: 28667027.

  13. Moore K, Java J, Slaughter K, Rose P, Lanciano R, DiSilvestro P, Thigpen JT, Lee YC, Tewari K, Chino J, Seward S, Miller D, Salani R, Moore, Stehman F. Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis. (2016) Gyn. Oncol. 143(2):294-301.

  14. Wong AT, Rineer J, Lee YC, Schwartz D, Safdieh J, Weiner J, Choi K, Schreiber D. (2016) Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma. Gyn. Oncol. 142(3):514-9.

  15. Osborn V, Schwartz D, Lee YC, Lee A, Garay E, Choi K, Han P, Schreiber D. Patterns of care of IMRT usage in postoperative management of uterine cancer. (2016) Gynecol Oncol. Nov 22. pii: S0090-8258(16)31573-6.

  16. Sherer DM, Palileo A, Graham S, Athanassiou A, Hamilton J, Abulafia O. (2016) Sonographic Depiction of a Non-Palpable Uterine Papillary Serous Carcinoma Metastasis Embedded within the Abdominal Wall. Ultrasound Obstet Gynecol. doi: 10.1002/uog.17308. [Epub ahead of print].

  17. Sherer DM, Moron A, Peirera L, Ward K, Benton L, Abulafia O. (2016) Transperineal Sonographic Findings of Vulvar Neurofibromatosis Type I. Ultrasound Obstet Gynecol. doi: 10.1002/uog.17213. [Epub ahead of print]

  18. Alagkiozidis I, Weedon J, Grossman A, Wang P, Mize B, Wilson K, Shah T, Economos K, Salame G, Abulafia O, Lee YC. (2015) Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma: A retrospective cohort study. Int J Surg. 24:9-13

  19. Sherer DM, Dalloul M, Behar HJ, Salame G, Holland R, Zinn H, Abulafia O. (2015) Peripartum Primary Prophylaxis Inferior Vena Cava Filter Placement in a Patient with Stage IV B-Cell Lymphoma Presenting with a Pathologic Femur Fracture. AJP Rep. 5(2):e129-31

  20. Sarafraz-Yazdi E, Gorelick C, Wagreich AR, Salame G, Angert M, Gartman CH, Gupta V, Bowne WB, Lee YC, Abulafia O, Pincus MR, Michl J. (2015) Ex vivo Efficacy of Anti-Cancer Drug PNC-27 in the Treatment of Patient-Derived Epithelial Ovarian Cancer.  Ann Clin Lab Sci. 45(6):650-8.

  21. Alagkiozidis I, Grossman A, Tang NZ, Weedon J, Mize B, Salame G, Lee YC, Abulafia O. (2015) Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study. Int J Surg. 14:61-6.

  22. Guitarte C, Alagkiozidis I, Mize B, Stevens E, Salame G, Lee YC. (2014) Glassy cell carcinoma of the cervix: A systematic review and meta-analysis. Gynecol Oncol. 133(2):186-91.

  23. Alagkiozidis I, Wilson K, Ruffner N, Weedon J, Serur E, Economos K, Abulafia O, Lee YC, Salame G. (2014) External validation of a nomogram for predicting survival of women with uterine cancer in a cohort of African-American patients. Int J Gynecol Cancer 24(1):85-90.

  24. Alagkiozidis I, Zhining NT, Berulava G, Abulafia O, Salame G. (2013) Port-site recurrence in a patient undergoing robotic hysterectomy and lymph node dissection for endometrioid adenocarcinoma of the uterus Gynecol Oncol Case Rep. 6:1-3.

  25. Alagkiozidis I, Salame G, Somma J, Herskovitz M, Levin D. (2013) Perioperative transcatheter embolization of a locally recurrent metastatic uterine leiomyoma. OA Case Reports 2(9):85.

  26. Jaffe J, Wang Z, Salame G, Lee YC, Alagkiozidis I. (2013) Extramedullary hematopoiesis mimicking metastatic lymphadenopathy in patient with squamous cell carcinoma of the vulva. OA Case Reports 2(10):92

  27. Stevens, E., Aquino, J., Barrow, N., Lee, YC. (2013) Ectopic Production of Human Chorionic Gonadotropin from a Synovial Sarcoma.  Obstetrics & Gynecology 121(2Pt2 S1): 468-71.

  28. Stevens, E., Pradhan, T., Chak, Y., Lee, YC. (2013)  A Case of Malignant Transformation of Endometriosis in a Cesarean Section Abdominal Wall Scar.  Journal of Reproductive Medicine 58(3):264-66.

  29. Stevens, E., Yu, S., Van Sise, M., Pradhan, T., Lee, V., Pearl, M.L, Lee, Y.C., Abulafia, O.  (2012) Relationship Between Hemoglobin A1c and Stage and Grade of Endometrial Cancer. Archives of Gynecology and Obstetrics 286(6): 1507-1512.

  30. Singh, L., Stevens E. (2012) Leg Pain and Gynecologic Malignancy.  J. of Hospice & Palliative Medicine [epub Sept 25, 2012]. DOI: 10.1177/1049909112460422

  31. Rana, R, Stevens, E, Singh, L, Shah Pradhan, T, Alagkiozidis, I, Salame, G, Lee, YC, Abulafia, O. (2012) Nationwide Chemotherapy Drug Shortages and the Impact on Patients with Gynecologic Malignancy at a Single Institution. Gynecologic Oncology 125(2): S190-191.

  32. Stevens, E, Leon, D, Blumberg, J, Pradhan, T, Salame, G, Abulafia, O, Lee, YC. (2012) Examining the Role of Preoperative Computerized Tomography in Serous Uterine Cancers. Gynecologic Oncology 125(S1): S71.

  33. Pradhan, T, Stevens, E, Agarwal, A, Salame, G, Lee, YC, Abulafia, O. (2012) The Diagnostic Utility and Cost-Analysis of Endometrial Biopsy versus Dilation and Curettage in Detecting Papillary Serous Carcinomas of the Uterus. Gynecologic Oncology, 124(S1): S72.

  34. Stevens, E, Rana, R, Jaffe, J, Blumberg, J, Pradhan, T, Lee, YC. (2012) Impact of race and age on duration between surgery and chemotherapy at a single institution. Gynecologic Oncology, 127(1): S31.

  35. Tang, N., Stevens, E., Lee, YC. (2012) VCare with the Lee Modification: Reaching New Boundaries in Radical Hysterectomy. Journal of Minimally Invasive Gynecology 19(6): S36.

  36. Leslie KK, Sill MW, Lankes HA, Fischer EG, Godwin AK, Gray H, Schilder RJ, Walker JL, Tewari K, Hanjani P, Abulafia O, Rose PG (2012) Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancer. Gynecol Oncol. 127(2):345-50.

  37. McMeekin DS, Sill MW, Darcy KM, Abulafia O, Hanjani P, Pearl ML, Rubin SC, Rose PG, Small L, Benbrook DM (2012) A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study. Gynecol Oncol. 127(2):356-61.

  38. Kunos C, Radivoyevitch T, Abdul-Karim FW, Fanning J, Abulafia O, Bonebrake AJ, Usha L.J (2012) Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study. Transl Med. 10:79.

  39. Stevens, E, Ogburn, P. (2011) Cesarean Scar Ectopic Pregnancy: Failed Combination Local and Systemic Methotrexate Management Requiring Surgical Intervention. J. of Reproductive Med. 56(4): 356-358.

  40. Alagkiozidis I, Dorcelus S, Somma J, Lee YC, Salame G. Invasive recurrence of serous borderline ovarian tumor as multifocal lymphadenopathy 25 years after initial diagnosis. Gynecologic Oncology Case Reports. 2(4): 136-138.

  41. Pradhan, T, Stevens, E, Ablavsky, M, Salame, G, Lee, YC, Abulafia, O. (2011) FIGO Staging for Carcinosarcoma: Can the New Staging System Predict Overall Survival?  Gyn. Oncology 123(2): 221-224.

  42. Pradhan T, Stevens E, Ablavsky M, Salame G, Lee YC, Abulafia O. (2011) FIGO Staging for carcinosarcoma: Can the new staging system predict overall survival? Gynecologic Oncology 120(S1): S116.

  43. Pradhan TS, Duan H, Katsoulakis E, Salame G, Lee YC, Abulafia O. (2011) Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer. Int J Gynecol Cancer 21(6): 1091-6.

  44. Covens L, Filiaci V, Gersell D, Lutman CV, Bonebrake A, Lee YC.  (2011) A Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol. 120(2): 158-8.

  45. Wagreich A, Salame G, Lee YC, Sherer DM, Abulafia O. (2010) Retroperitoneal tuberculosis in a patient with uterine papillary serous carcinoma. Eur J Gynecol Reprod Biol. 149:230-231.

  46. Pradhan T, Salame G, Duan H, Abulafia O, Lee YC,Weedon J, Katsoulakis E. (2010) Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer.Poster presentation and abstract: IGCS, Biennial Meeting. Prague, Czech Republic. October 2010

  47. Miller BE, Blessing JA, Stehman FB, Shahin MS, Yamada SD, Secord AA, Warshal DP, Abulafia O, Richards WE, Van Le L. (2010) A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecol Oncol. 118(2):139-44. 

Updated May 2020.